|
CN101912469A
|
|
Application of extract of bolus for reinforcing middle jiao and replenishing qi in radiation protection
|
|
CN101836972A
|
|
Novel purposes of ferulic acid
|
|
CN101899440A
|
|
Structure and use of PITPNM2 targeted anti-dengue virus oligonucleotide
|
|
CN101822654A
|
|
Pentetate inhalant
|
|
CN101822636A
|
|
Slowly released and controlled-drug delivery system of injectable estriol
|
|
CN101862316A
|
|
Application of vanillic acid in prevention and treatment of radiation injury
|
|
CN101617995A
|
|
Composition with sweat-restricting, deodorization and washing functions
|
|
CN101957379A
|
|
HPPCn antibody, antisense oligonucleotide and application of RNA interference in tumor diagnosis and treatment
|
|
CN101923079A
|
|
Mixed capillary chromatographic column with shower head and preparation method thereof
|
|
CN101536999A
|
|
Application of 3,5-dimethoxy-4-hydroxy benzaldehyde in ray protection
|
|
CN101639941A
|
|
Method for extracting binuclear lymphocyte accurately and quickly in CB method micronucleated cell image
|
|
CN101281562A
|
|
Method for quantitative analyzing RNA mutation harmfulness
|
|
CN101105493A
|
|
Method for detecting protein interaction by immunological coprecipitation based on protein chip and reagent kit for detecting protein interaction
|
|
CN1896100A
|
|
Liver regenerated factor and its use
|
|
CN101063129A
|
|
Structure and usage of antisense oligonucleotide inhibiting ABHD2 gene expression
|
|
CN1844387A
|
|
Antisense oligonucleotide structure inhibiting Sirt1 gene expression and use thereof
|
|
CN1961877A
|
|
Pharmaceutical composition for treating withdrawal syndrome
|
